Key statistics
On Thursday, Aldeyra Therapeutics Inc (ALDX:NAQ) closed at 6.04, -10.39% below its 52-week high of 6.74, set on Oct 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.07 |
---|---|
High | 6.10 |
Low | 5.86 |
Bid | 6.00 |
Offer | 6.10 |
Previous close | 5.87 |
Average volume | 404.19k |
---|---|
Shares outstanding | 59.42m |
Free float | 48.69m |
P/E (TTM) | -- |
Market cap | 358.91m USD |
EPS (TTM) | -0.6387 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
- Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap